Accumulation of galactose in dairy products due to partial lactose fermentation by lactic acid bacteria yields poor-quality products and precludes their consumption by individuals suffering from galactosemia. This study aimed at extending our knowledge of galactose metabolism in Lactococcus lactis, with the final goal of tailoring strains for enhanced galactose consumption. We used directed genetically engineered strains to examine galactose utilization in strain NZ9000 via the chromosomal Leloir pathway (gal genes) or the plasmid-encoded tagatose 6-phosphate (Tag6P) pathway (lac genes). Galactokinase (GalK), but not galactose permease (GalP), is essential for growth on galactose. This finding led to the discovery of an alternative route, comprising a galactose phosphotransferase system (PTS) and a phosphatase, for galactose dissimilation in NZ9000. Introduction of the Tag6P pathway in a galPMK mutant restored the ability to metabolize galactose but did not sustain growth on this sugar. The latter strain was used to prove that lacFE, encoding the lactose PTS, is necessary for galactose metabolism, thus implicating this transporter in galactose uptake. Both PTS transporters have a low affinity for galactose, while GalP displays a high affinity for the sugar. Furthermore, the GalP/Leloir route supported the highest galactose consumption rate. To further increase this rate, we overexpressed galPMKT, but this led to a substantial accumulation of ␣-galactose 1-phosphate and ␣-glucose 1-phosphate, pointing to a bottleneck at the level of ␣-phosphoglucomutase. Overexpression of a gene encoding ␣-phosphoglucomutase alone or in combination with gal genes yielded strains with galactose consumption rates enhanced up to 50% relative to that of NZ9000. Approaches to further improve galactose metabolism are discussed.
Lactococcus lactis is a lactic acid bacterium widely used in the dairy industry for the production of fermented milk products. Because of its economic importance, L. lactis has been studied extensively in the last 40 years. A small genome, a large set of genetic tools, a wealth of physiological knowledge, and a relatively simple metabolic potential render L. lactis an attractive model with which to implement metabolic engineering strategies (reviewed in references 21 and 57).
In the process of milk fermentation by L. lactis, lactose is taken up and concomitantly phosphorylated at the galactose moiety (C-6) by the lactose-specific phosphoenolpyruvate (PEP)-dependent phosphotransferase system (PTS Lac ), after which it is hydrolyzed to glucose and galactose 6-phosphate (Gal6P) (64) . The glucose moiety enters the glycolytic pathway upon phosphorylation via glucokinase to glucose 6-phosphate (G6P), whereas Gal6P is metabolized to triose phosphates via the D-tagatose 6-phosphate (Tag6P) pathway, encompassing the steps catalyzed by galactose 6-phosphate isomerase (LacAB), Tag6P kinase (LacC), and tagatose 1,6-bisphosphate aldolase (LacD) (Fig. 1) . Curiously, during the metabolism of lactose by L. lactis, part of the Gal6P is dephosphorylated and excreted into the growth medium, while the glucose moiety is readily used (2, 7, 51, 56, 60) .
As a result of incomplete lactose utilization, some fermented dairy products contain significant residual amounts of galactose. The presence of galactose has been associated with shoddier qualities of the fermented product (6, 27, 43) . In particular, galactose is a major contributor to the browning that occurs when dairy products (e.g., yogurt and mozzarella, Swiss, and cheddar cheese) are cooked or heated in the manufacture of pizzas, sauce preparation, or processed cheese. In addition, availability of residual galactose may result in production of CO 2 by heterofermentative starters and, consequently, in textural defects such as the development of slits and fractures in cheeses. Therefore, the availability of starter strains with improved galactose utilization capacity is desirable to develop higher-quality dairy products. Additionally, strains with increased galactose metabolism could provide galactose-free foods for individuals and, in particular, children suffering from the rare disease galactosemia (36) . To this end, a comprehensive understanding of galactose catabolism is essential. Galactose metabolism in L. lactis was thoroughly studied in the past and has been and still is the subject of some controversy. Indeed, conflicting results regarding the type of PTS involved in galactose uptake have been published. Some authors advocated that galactose is exclusively transported via the plasmid-encoded PTS Lac , whereas others proposed transport via a galactose-specific PTS (PTS Gal ) to the extreme of questioning the contribution of the PTS Lac (17, 20, 50, 59) . However, a gene encoding PTS Gal has never been identified in L. lactis. Independently of the nature of the PTS, it is generally accepted that the resulting Gal6P is metabolized via the Tag6P pathway (lac operon) (Fig. 1) . On the other hand, galactose translocated via the highly specific galactose permease (GalP) is metabolized via the Leloir pathway to ␣-glucose 1-phosphate (␣-G1P) through the sequential action of galactose mutarotase (GalM), galactokinase (GalK), and galactose 1-phosphate uridylyltransferase (GalT)/UDP-galactose-4-epimerase (GalE) (gal operon). Entry in glycolysis is preceded by the ␣-phosphoglucomutase (␣-PGM)-catalyzed isomerization of ␣-G1P to G6P. The use of the Leloir and/or the Tag6P pathway for galactose utilization is currently viewed as being strain dependent (9, 16, 25, 32, 33, 58) , but the relative efficacy in the degradation of the sugar has not been established.
The ultimate aim of this study was to engineer L. lactis for improved galactose-fermenting capacity as a means to minimize the galactose content in dairy products. To gain insight into galactose catabolism via the Leloir (gal genes) and the Tag6P (lac genes) pathways, a series of L. lactis subsp. cremoris NZ9000 isogenic gal and lac mutants were constructed. Carbon 13 labeling experiments coupled with nuclear magnetic resonance (NMR) spectroscopy were used to investigate galactose metabolism in the gal and lac strains. The data obtained revealed a novel route for galactose dissimilation and provided clues to further enhance galactose utilization.
MATERIALS AND METHODS
Microbial strains used and growth conditions. The strains and plasmids used in this study are listed in Table 1 . For genetic manipulation, strains were routinely grown at 30°C in M17 broth (Difco, Sparks, MD) containing 0.5% (wt/vol) glucose. For physiological characterization, cultures were grown in chemically defined medium (CDM) (52) with 1% (wt/vol) galactose under anaerobic conditions in rubber-stoppered bottles (200 ml) or in a 2-liter fermentor (Biostat MD; B. Braun Biotech International, Melsungen, Germany) and at a temperature of 30°C. When appropriate, erythromycin or chloramphenicol was used at 5 g ml
Ϫ1
. Expression of genes cloned downstream of the nisin-inducible P nisA promoter was induced when the optical density at 600 nm (OD 600 ) was between 0.25 and 0.5 by addition of a supernatant (0.01%, vol/vol) of an overnight culture of the nisin producer L. lactis NZ9700 (29) or by addition of a nisin solution (1 g liter Ϫ1 in a 50% [vol/vol] ethanol solution). In the fermentor, the medium was gassed with argon for 60 min prior to inoculation (4% inoculum from a culture grown overnight). The pH was kept at 6.5 by automated addition of 10 M NaOH, and an agitation rate of 70 rpm was used to keep the system homogeneous. Growth was monitored by measuring the OD 600 . Specific growth rates () were calculated through linear regressions of the plots of ln(OD 600 ) versus time during the exponential growth phase.
General DNA manipulations. General DNA techniques were performed essentially as described before (55) . Plasmid DNA was isolated by the method of Birnboim and Doly (8) . Restriction enzymes, T4 DNA ligase, Expand polymerase, and Taq DNA polymerase were obtained from Roche Diagnostics GmbH (Mannheim, Germany) and were used according to the supplier's instructions. PCR amplifications were performed in an Eppendorf thermal cycler (Eppendorf, Hamburg, Germany) with L. lactis MG1363 chromosomal DNA as the template, unless described otherwise, using appropriate conditions. The primers used in this study are described in Table 2 .
Construction of overexpression vectors. Cloning of genes involved in the Leloir pathway was performed as follows: the PCR products obtained with primer pairs GalA1-fw/GalA-rev and GalA1-fw/GalT-rev were cloned as 1.39-kb and 6.60-kb Eco31I/XbaI restriction fragments in NcoI/XbaI-restricted pNG8048e, resulting in plasmids pGalP (galP cloned downstream of the nisin-inducible promoter P nisA ) and pGalPMKT (galPMKT downstream of P nisA ), respectively. The plasmids were introduced by electrotransformation (26) into L. lactis NZ9000.
To clone the pgmA gene (1.72 kb) of Streptococcus thermophilus ST11, primers were designed on the sequence of S. thermophilus LY03 (accession number IMDST01, culture collection at VU, Brussels, Belgium). The PCR products obtained with primer pair PgmA-fw1/PgmA-rev or PgmA-fw2/PgmA-rev were cloned as NcoI/XbaI or XbaI restriction fragments in NcoI/XbaI-restricted pNZ8048 to obtain pPgmA and in XbaI-restricted pGalP and pGalPMKT to obtain pGalPpgmA and pGalPMKTpgmA, respectively. Variants of the plasmids that carried pgmA downstream and in the same orientation as the gal gene(s) were selected in L. lactis NZ9000. Plasmid constructs were checked by EcoRI restriction enzyme analysis.
The Tag6P pathway genes lacFE, lacABCD, and lacABCDFE were amplified by PCR using pMG820 DNA as the template and primer pairs LacFE-fw/LacFErev, LacAD-fw/LacAD-rev, and LacAE-fw/LacAE-rev ( Table 2 ). The overexpression plasmids pLacFE, pLacABCD, and pLacABCDFE were constructed by cloning the 2.04-kb RcaI/XbaI, 2.89-kb PtsI/SpeI, and 4.95-kb SphI/SpeI restriction fragments into NcoI/XbaI-, PtsI/SpeI-, and SphI/SpeI-restricted pNZ8048, respectively. lacG was amplified using primer pair LacG-fw and LacG-rev, restricted with SacI, and cloned into SacI-restricted pLacABCDFE. The lacG orientation in pLacABCDFEG was confirmed by restriction enzyme analysis. The resulting constructs were transformed (26) into L. lactis NZ9000⌬galPMK.
Construction of galP-and galPMK-deletion strains. The PCR products obtained with primer pairs GalA-KO1/GalA-KO2 and GalA-KO3/GalA-KO4 were cloned together as XbaI/BamHI and BamHI/EcoRI restriction fragments in XbaI/EcoRI-restricted pORI280 (35) , resulting in pORI280-galPЈ. This plasmid FIG. 1. Schematic overview of the alternative routes for galactose uptake and further catabolism in L. lactis. Galactose can be imported by the non-PTS permease GalP and metabolized via the Leloir pathway (galMKTE) to ␣-G1P, which is converted to the glycolytic intermediate G6P by ␣-phosphoglucomutase (pgmH). Alternatively, galactose can be imported by PTS Lac (lacFE) and further metabolized to triose phosphates by the Tag6P pathway (lacABCD). Here, we propose a new uptake route consisting of galactose translocation via the galactose PTS, followed by dephosphorylation of the internalized Gal6P to galactose, which is further metabolized via the Leloir pathway (highlighted in the gray box). galP, galactose permease; galM, galactose mutarotase; galK, galactokinase; galT, galactose 1-phosphate uridylyltransferase; galE, UDP-galactose-4-epimerase; pgmH, ␣-phosphoglucomutase; lacAB, galactose 6-phosphate isomerase; lacC, Tag6P kinase; lacD, tagatose 1,6-bisphosphate aldolase; lacFE, PTS Lac ; PTS Gal , unidentified galactose PTS; Phosphatase; unidentified Gal6P-phosphatase; pgi, phosphoglucose isomerase; pfk, 6-phosphofructo-1-kinase; fba, fructose 1,6-bisphosphate aldolase; tpi, triose phosphate isomerase; ␣-Gal1P, ␣-galactose 1-phosphate; ␣-G1P, ␣-glucose 1-phosphate; UDP-gal, UDP-galactose; UDP-glc, UDP-glucose; G6P, glucose 6-phosphate; Gal6P, galactose 6-phosphate; Tag6P, tagatose 6-phosphate; TBP, tagatose 1,6-bisphosphate; FBP, fructose 1,6-bisphosphate; DHAP, dihydroxyacetone phosphate; GAP, glyceraldehyde 3-phosphate. The dotted arrow represents the conversions of GAP to pyruvate via the glycolytic pathway. Steps essential to improve galactose consumption are shown in black boxes.
was obtained using L. lactis LL302 (34) as the cloning host. PCR products obtained with primer pairs GalA-KO1/GalA-KO2 and GalAMK-KO5/GalAMK-KO6 were cloned as XbaI/BamHI and BamHI/EcoRI restriction fragments in XbaI/EcoRI-restricted pORI280, resulting in pORI280-galPMKЈ, which was obtained and maintained in L. lactis LL302. Introducing pORI280-galPЈ or pORI280-galPMKЈ together with helper plasmid pVE6007 in L. lactis NZ9000, followed by a two-step homologous recombination event (35) , yielded strains NZ9000⌬galP and NZ9000⌬galPMK, respectively. The chromosomal structures of both strains were confirmed by PCR analysis and Southern blotting using enhanced chemiluminescence (ECL) detection (Amersham Pharmacia Biotech) with a PCR fragment obtained with primer pair GalA-KO1/GalA-KO2 as the probe. Enzyme assays. For enzymatic assays, cells were disrupted using 0.5 g glass beads (diameter, 50 to 105 m; Fischer Scientific BV, Den Bosch, Netherlands) and a Mini-BeadBeater-8 apparatus (Biospec Products, Inc., Bartlesville, OK) with two 1-min pulses separated by 1 min of cooling down on ice. Cell debris was pelleted, and activities were assayed at 30°C. Protein concentrations were determined by the method of Bradford (11) .
(i) ␣-Phosphoglucomutase. Cell cultures grown to an OD 600 of 0.25 were treated with nisin (0.01% [vol/vol] supernatant of NZ9700), as described above. When the cultures reached an OD 600 of 1 (approximately 4 h after induction), the cells were centrifuged (2,500 ϫ g, 7 min), washed twice with potassium phosphate (KP i ) buffer (10 mM, pH 7.2), and resuspended in the same buffer. ␣-PGM specific activity in cell extracts was assayed as described by Qian et al. (54) . The 1-ml assay mixture contained 50 mM triethanolamine-HCl (TEA; pH 7.2), 5 mM MgCl 2 , 0.5 mM NADP ϩ , 50 M glucose-1,6-bisphosphate, and 1.75 U glucose-6-phosphate dehydrogenase. Reactions were started by the addition of 1.5 mM ␣-G1P. One unit of enzyme is defined as the amount of enzyme 
catalyzing the conversion of 1 mol of substrate (NADP ϩ ) per min assayed at 340 nm.
Activities involved in galactose catabolism in L. lactis strain NZ9000⌬galP. Cells were grown in galactose (0.5%, wt/vol)-CDM, harvested in the mid-exponential phase of growth, centrifuged (2,500 ϫ g, 7 min), washed twice with TEA buffer (50 mM, pH 7.2), and resuspended in the same buffer, after which cell extracts were prepared. All the reaction mixtures contained 50 mM TEA buffer, pH 7.2, 5 mM MgCl 2 , and cell extract (about 2 mg total protein) in a final volume of 0.55 ml. The reactions were initiated by the addition of 5 mM sugar substrate (Gal6P, Gal1P, or galactose). After 1 h of incubation at 30°C, 50 l of 2 H 2 O was added and the reaction products were analyzed by 31 P NMR spectroscopy. Alternatively, the reactions were monitored online, and 31 P spectra were acquired every 2.5 min. ATP and the phosphatase inhibitor sodium fluoride were added to the reaction mixtures to final concentrations of 2.5 mM and 10 mM, respectively. ␣-Glucose 1,6-bisphosphate (50 M) was added when appropriate. 31 P NMR spectra were recorded using a selective probe head ( 31 P-SEX) at 30°C on an Avance II 500-MHz spectrometer (Bruker BioSpin GmbH, Karlsruhe, Germany) by using standard Bruker pulse programs. Spectra were referenced to the resonance of external 85% H 3 PO 4 , designated 0 ppm.
Galactose PTS assay. L. lactis strain NZ9000⌬galP was grown to an optical density at 600 nm of 2.2 in galactose-CDM, and PTS activity was determined as described by LeBlanc et al. (32) . Briefly, 20 ml of late-exponential-phase cells was harvested, washed twice with KP i buffer (100 mM, pH 7.2), and suspended in 5 ml of the same buffer supplemented with MgCl 2 (5 mM). The cells in this suspension were permeabilized with 250 l of toluene-acetone (1:9), and 50 l of permeabilized cells was used in the assays. The 1-ml assay mixture contained 100 mM KP i (pH 7.2), 5 mM MgCl 2 , 15 mM NADH, 10 U lactate dehydrogenase, 10 mM NaF, and 20 mM galactose. Reactions were started by the addition of 5 mM PEP. The oxidation of NADH was measured in a PEP-dependent manner.
In vivo NMR spectroscopy. Carbon-13 spectra were acquired at 125.77 MHz on an Avance II 500-MHz spectrometer (Bruker BioSpin GmbH). All in vivo experiments were run using a quadruple nucleus probe head at 30°C, as described before (46) . Cells were harvested in the mid-logarithmic phase of growth, washed twice with 5 mM KP i buffer (pH 6.5), and resuspended in 50 mM KP i (pH 6.5) to a protein concentration of approximately 15 mg protein ml Ϫ1 . In vivo NMR experiments were performed using the online system described earlier, which consists of a minibioreactor coupled to NMR detection with a circulating system that allows noninvasive studies of metabolism under controlled conditions of pH, gas atmosphere, and temperature (46) . Galactose specifically labeled with 13 C on carbon 1 (20 mM) was added to the cell suspension at time zero. The time courses of galactose consumption, product formation, and changes in the pools of intracellular metabolites were monitored in vivo. When the substrate was exhausted and no changes in the resonances of intracellular metabolites were observed, an NMR sample extract was prepared as described previously (46, 48) . The lactate in the NMR sample extract was quantified by 1 H NMR in an AMX300 spectrometer (Bruker BioSpin GmbH). The concentrations of the other metabolites were determined in fully relaxed 13 C spectra of the NMR sample extracts as described previously (48) . Due to the fast pulsing conditions used for acquiring in vivo 13 C spectra, correction factors were determined to convert peak intensities into concentrations (45, 46) . The quantitative kinetic data for intracellular metabolites were calculated as described elsewhere (47, 48) . The lower limit for in vivo NMR detection of intracellular metabolites under these conditions was 3 to 4 mM. Intracellular metabolite concentrations were calculated using a value of 2.9 l (mg of protein)
Ϫ1 for the intracellular volume of L. lactis (53) . Although the results of individual experiments are illustrated in each figure, each experiment was repeated at least twice and the results were highly reproducible. The values reported are averages of two experiments, and the accuracy varied from Ϯ2% (extracellular products) to Ϯ10% in the case of intracellular metabolites with concentrations below 5 mM and varied from Ϯ5% to Ϯ10% for the maximal galactose consumption rate.
Analysis of [1-
13
C]galactose fermentation products by 1 H NMR. L. lactis NZ9000⌬galPMK and derivatives carrying pMG820 or each of the lac constructs were grown in M17 broth with 1% glucose and an initial pH of 6.5. When appropriate, chloramphenicol (5 g ml Ϫ1 ) was added. Nisin (Sigma, St. Louis, MO) at a concentration of 1 g l Ϫ1 was added when the OD 600 of the cultures reached approximately 0.4. After 2 h of induction, cells were harvested, washed twice (50 mM KP i , pH 6.5), resuspended at a concentration of approximately 5 mg protein ml Ϫ1 in KP i buffer (50 mM, pH 6.5), and placed in tubes with a rubber stopper. Argon was bubbled through the suspension for 10 min to ensure anaerobiosis. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]galactose (20 mM) was added, and the supernatant was recovered following 1 h of incubation at 30°C with mild agitation to keep the system homogeneous. The H NMR spectra were acquired in a Bruker AMX300 spectrometer using a 5-mm inverse detection probe head, 32,000 data points, a 90°flip angle, and a repetition delay of 42.7 s. The water resonance was suppressed with a presaturation pulse.
Transcriptome analysis. The levels of transcripts in NZ9000⌬galP grown on galactose were compared by transcriptome analysis using full-genome ampliconbased L. lactis MG1363 DNA microarrays, and the levels of mRNA in NZ9000⌬galP grown on glucose or the levels of mRNA in NZ9000 grown on galactose were determined as described elsewhere (30) . Cells were grown in CDM in rubber-stoppered bottles as described above and harvested at an OD 600 of 0.25. The experiments were performed essentially as described elsewhere (62) with the modifications introduced previously (51) .
Chemicals. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]galactose (99% enrichment) was obtained from Euriso-top (Gif-Sur-Yvette, France). Formic acid (sodium salt) was purchased from Merck Sharp & Dohme (Whitehouse Station, NJ). Nisin was obtained from SigmaAldrich (St. Louis, MO). All other chemicals were reagent grade.
RESULTS
L. lactis NZ9000 can import galactose via more than one transport system. L. lactis can use the Leloir pathway, the Tag6P pathway, or both pathways for galactose metabolism in a strain-dependent manner (58) . Presumably, L. lactis subsp. cremoris NZ9000 (MG1363pepN::nisRK) internalizes galactose by a secondary carrier symporter (GalP) and further metabolizes the sugar exclusively via the Leloir pathway (25) , as this strain lacks the plasmid-linked genes encoding the Tag6P pathway. To assess the potential of the Tag6P route for galactose catabolism, a strategy was devised that consisted of introduction of plasmid pMG820 (41) with genes lacABCDFEG, encoding the lactose PTS (lacFE), the Tag6P pathway enzymes (lacABCD), and a ␤-phosphogalactosidase (lacG) (64) , in mutants in which galactose utilization via the Leloir pathway was prevented. Grossiord et al. (25) previously reported blockage of the Leloir pathway by inactivation of the galactose permease gene. In our study, galP was deleted in strain NZ9000 using a double-crossover recombination method. The extent of the deletion is shown in Fig. 2A . Unexpectedly, L. lactis NZ9000⌬galP was still able to grow in a medium with galactose as the sole carbon source (Fig. 2B) ; growth was biphasic and characterized by an initial growth rate that was 2.3-fold lower than a second growth rate, which was similar to that of parent strain NZ9000 (0.38 Ϯ 0.01 h Ϫ1 ). To exclude the possibility of residual GalP activity due to partial deletion only ( Fig. 2A) , a new out-of-frame deletion was made in which only the first four amino acids of the original protein were left. The behavior of the resulting strain was in all aspects similar to that of our original galP-deletion strain. Subsequently, a mutant strain of L. lactis NZ9000 was made in which, apart from galP, the downstream genes of the operon, galM (galactose mutarotase) and galK (galactose kinase), were also deleted ( Fig. 2A) . Deletion of galPMK resulted in total loss of the capacity to grow in a medium with galactose as the sole source of carbon (Fig.  2B) . These data imply that L. lactis NZ9000 has an additional transport system with specificity for galactose.
L. lactis NZ9000 can catabolize galactose via the Tag6P pathway. Introduction of pMG820 in L. lactis NZ9000⌬galPMK rendered a strain that could grow in CDM containing lactose (or glucose, both at 1% [wt/vol]) but not when galactose (1% wt/vol) was the sole carbon source (data not shown). However, resting cells of lactose-grown cultures were able to convert [1- (Fig. 3) . To determine which of the genes within the lac operon were essential for galactose metabolism, the following combinations of genes were cloned into pNZ8048 under the control of the nisin promoter: lacABCD, lacFE, lacABCDFE, and lacABCDFEG. The various constructs were introduced into L. lactis NZ9000-⌬galPMK. Expression of the lac genes in the different constructs was confirmed by SDS-PAGE of cell extracts obtained from nisin-induced (1 g liter
Ϫ1
) glucose-grown cultures (data not shown). Also, strain NZ9000⌬galPMK(pLacABCDFEG) was able to grow on lactose (1%, wt/vol)-CDM when the inducer nisin (1 g liter Ϫ1 ) was added at time 0 h (inoculation). Strain NZ9000⌬galPMK(pLacABCDFE) showed moderate growth under the same conditions (Table 3) , thus showing functional expression of the lac genes. Like NZ9000⌬galPMK(pMG820), none of the resulting strains was able to grow in CDM with galactose (1%, wt/vol) as the carbon source, even though nisin was added at time 0 h. To determine the galactose-fermenting capacity of NZ9000⌬galPMK and derivatives harboring the lac constructs, resting cell suspensions were incubated with [1- 1 H NMR spectra of end products formed from the metabolism of [1-13 C]galactose (20 mM) by cell suspensions of NZ9000⌬galPMK and derivatives carrying different lac operon constructs (pLacFE, pLacABCD, pLacABCDFE) or pMG820 at an initial pH of 6.5 and under anaerobic conditions. Cell suspensions were prepared as described in Materials and Methods. Expression of the lac genes under the control of P nisA was induced by the addition of 1 g liter Ϫ1 nisin. 1 H NMR spectra were acquired after a 10-fold dilution in 2 H 2 O in a Bruker AMX300 spectrometer with a 5-mm inverse detection probe head and processed with 0.1-Hz line broadening. Isotopomers of lactate, acetate, and ethanol are indicated. The end-product profile of NZ9000(pLacABCDFEG) was identical to that of NZ9000(pLacABCDFE) and was omitted for the sake of simplicity. pLacFE, PTS Lac ; pLacABCD, Tag6P pathway; pLacABCDFE, PTS Lac and Tag6P pathway. (Fig. 3) . Strains NZ9000-⌬galPMK(pLacABCD) and NZ9000⌬galPMK(pLacFE) and the negative control, NZ9000⌬galPMK, were unable to metabolize galactose, as indicated by the absence of labeled end products in the supernatants. Lactate labeled on carbon 3 was detected in the supernatants of NZ9000⌬galPMK(pLacABCDFE) and NZ9000⌬galPMK(pLacABCDFEG), showing that, under the conditions tested (glucose-grown cells), both the Tag6P enzymes (lacABCD) and PTS Lac (lacFE) are required for galactose consumption in L. lactis NZ9000⌬galPMK.
Consumption rate and glycolytic dynamics depend on the route for galactose utilization. The metabolism of [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] C]galactose (20 mM) in resting cells of strains NZ9000 and NZ9000⌬galP grown on galactose and strain NZ9000⌬galPMK(pMG820) grown on lactose was studied by in vivo 13 C NMR (Fig. 4) . The kinetics of galactose consumption in NZ9000 was characterized by an initial lag phase followed by quasilinear galactose consumption with a maximal rate of 0.16 Ϯ 0.01 mol min Ϫ1 (mg of protein) Ϫ1 (Fig. 4A) . During the quasilinear consumption period, ␣-Gal1P and ␣-G1P, the phosphorylated intermediates of the Leloir pathway, accumulated to maximal concentrations of a Lactose was present at 0.5% (wt/vol). The OD 600 was evaluated every 12 h for a period of 48 h. Precultures were grown in CDM with glucose (1%, wt/vol).
FIG. 4. Metabolism of galactose in suspensions of nongrowing cells of L. lactis NZ9000 and its derivatives. Kinetics of [1-
13 C]galactose (20 mM) consumption and end-product formation (A, C, and E) as well as pools of intracellular metabolites (B, D, and F) in resting cells of L. lactis strains NZ9000 (A and B), NZ9000⌬galPMK(pMG820) (C and D), and NZ9000⌬galPMK (E and F) under anaerobic conditions at 30°C with the pH controlled at 6.5, as monitored by in vivo 13 Strain NZ9000⌬galPMK(pMG820) presumably assimilates galactose via the plasmid-encoded PTS Lac and Tag6P pathway activities. In this strain, the kinetics of galactose consumption was biphasic: quasilinear consumption with a maximal rate of 0.06 Ϯ 0.01 mol min Ϫ1 (mg of protein) Ϫ1 was followed by a second phase at a rate approximately 3-fold lower (Fig. 4C) . A similar profile for substrate consumption had previously been observed in an L. lactis strain having cellobiose-specific PTS (PTS Cel ) as the single glucose transporter (13) , and it resulted from a strong preference for the ␤-glucose anomer. In contrast, the second phase of galactose consumption is not associated with PTS Lac anomeric specificity, as the ratio between ␣-and ␤-galactose utilization rates remains constant throughout the experiment (data not shown). Therefore, in strain NZ9000⌬galPMK(pMG820), the slowdown in galactose consumption 17 min after its addition (galactose concentration, Ͻ4.5 mM) is probably a consequence of a low affinity for galactose transport via PTS Lac , which is in agreement with previously reported K m values in the mM range (32) . Using a mathematical model with Michaelis-Menten formalism (13), a K m value of approximately 8.4 mM was estimated for galactose uptake in NZ9000⌬galPMK(pMG820). The same model predicted a K m of galactose uptake by strain NZ9000 of approximately 0.4 mM, a value close to that reported for galactose uptake via a permease (K m , 0.13 mM) (59) . Accumulation of the Tag6P pathway intermediate tagatose 1,6-bisphoshate (maximal concentration, about 10 mM) occurred within seconds after addition of galactose (Fig. 4D ), but Gal6P was not detected in vivo by 13 C NMR. In the spectra acquired during the metabolism of [1- 13 C]galactose, a resonance due to FBP labeled in C-6 (␦, 65.1 ppm) appeared soon after (about 1.5 min) the C-1 peak of tagatose 1,6-bisphoshate (␦, 66.4 ppm) became detectable. Tagatose 1,6-bisphoshate labeled in C-6 (␦, 63.4 ppm) was not detected. The observed labeling pattern is consistent with scrambling of the 13 C label at the level of triose phosphates and backflux through aldolase (46) . Indeed, the FBP pool showed a profile identical to that of tagatose 1,6-bisphoshate, but the maximal concentration was somewhat lower (6.5 Ϯ 1.1 mM). Accumulation of 3-PGA, a metabolite generally associated with substrate starvation, occurred while galactose was still abundant; likewise, PEP was also detected before galactose exhaustion.
The profile of galactose consumption in strain NZ9000⌬galP resembled that in NZ9000⌬galPMK(pMG820), as it also displayed biphasic kinetics, but the rate of the first phase was nearly 2-fold higher [0.11 Ϯ 0.01 mol min Ϫ1 (mg of protein) Ϫ1 ] and that of the second phase was considerably shorter (Fig. 4E) . The observed behavior (biphasic kinetics) strongly indicates the presence of a transporter with a low affinity for galactose in this strain. The estimated K m value for galactose uptake is about 6.3 mM. Inactivation of galP apparently caused no loss of expression of the downstream genes galMKTE in the gal operon (galPMKTE), as accumulation of ␣-Gal1P and ␣-G1P during the metabolism of galactose denoted functional GalKTE enzyme activities (Fig. 4F) . Indeed, a whole-genome transcription analysis revealed no significant differences in the expression levels of galMKTE genes in NZ9000⌬galP and NZ9000 cells grown on galactose. In contrast, in the galP mutant the expression levels of galMKT and galE were about 50-fold and 8-fold higher, respectively, during growth on galactose compared to growth on glucose. FBP was detected only about 2.5 min after galactose addition, reached a steady concentration of 15.9 Ϯ 1.5 mM during the rapid phase, and decreased to undetectable levels before galactose depletion. As was the case in NZ9000, Gal6P accumulated immediately (concentration, about 4 mM) after galactose addition, decreasing to undetectable levels, however, during the transition from the first to the second phase of galactose consumption. Concomitantly, 3-PGA and PEP pools rose to 38.1 Ϯ 2.8 and 11.0 Ϯ 2.2 mM, respectively.
Initial steps for galactose utilization in strain NZ9000⌬galP. The in vivo 13 C NMR data obtained during the metabolism of galactose in strain NZ9000⌬galP showed accumulation of ␣-Gal1P, which originates from the ATP-dependent phosphorylation of galactose by GalK. However, mining of the L. lactis MG1363 genome revealed no clear candidate gene for a galactose permease alternative to galP. Additionally, detection of Gal6P immediately after the addition of galactose to cell suspensions of NZ9000⌬galP (and also NZ9000) is indicative of a galactose PTS activity. Indeed, galactose translocation by a PTS other than the PTS Lac has previously been suggested in L. lactis (50, 59) . Therefore, we hypothesized that transport of galactose in strain NZ9000⌬galP is mediated via a PTS, leading to Gal6P, which is subsequently (in)directly converted to ␣-Gal1P and further metabolized via the Leloir pathway. Specific galactose PTS activity was assayed using permeabilized cells of galactose-grown NZ9000 ⌬galP: a value of 50 Ϯ 2 nmol min Ϫ1 (mg of protein) Ϫ1 was determined. The step(s) involved in the conversion of Gal6P to ␣-Gal1P was investigated by incubating cell-free NZ9000⌬galP extracts with appropriate phosphorylated substrates coupled to 31 P NMR analysis. A considerable (2-fold) decrease in the resonance due to Gal6P (␦, 4.25 ppm) accompanied by an increase in P i (␦, 2.28 ppm) was observed upon incubation of Gal6P with cell extract (Fig.  5A ). When the reaction was performed in the presence of the phosphatase inhibitor NaF, no changes in the Gal6P and P i resonances were detected. The data show that Gal6P phosphatase activity is present in L. lactis. Direct conversion of Gal6P into ␣-Gal1P was not observed, ruling out the presence of a phosphogalactomutase activity. The paucity of phosphohexomutase genes in the genome sequence of L. lactis MG1363 (65) and the lack of specificity for phosphogalactose by the lactococcal ␣-phosphoglucomutase (45) further support the absence of such a phosphogalactomutase activity.
A resonance due to ␣-Gal1P (␦, 2.55 ppm) was readily detected upon addition of ATP (2.5 mM) to a reaction mixture in which dephosphorylation of Gal6P by the cell extract had occurred (Fig. 5B) . The results show that conversion of Gal6P to ␣-Gal1P entails sequential dephosphorylation and phosphorylation steps, which are catalyzed by a yet uniden- tified phosphatase and GalK, respectively. The requirement for a functional galactokinase is clear from the inability of strain NZ9000⌬galPMK to metabolize galactose (Fig. 3) . At this point, it should be noted that the inability of strain NZ9000⌬galPMK(pLacABCD) to metabolize galactose is not in contradiction to the presence of an alternative galactose PTS in the genome. Rather, this result implies that expression of such a transporter needs to be induced by galactose. In agreement, suspensions of glucose-grown NZ9000⌬galPMK cells incubated with [1-13 C]galactose failed to accumulate [1- 13 C]Gal6P (data not shown), as opposed to NZ9000 and NZ9000⌬galP cells grown on galactose (Fig. 4) . Also in line with this view is the observed growth behavior of strain NZ9000⌬galP in galactose-CDM (Fig. 2) , with the initial low growth rate suggesting the need to express new activities for full growth on galactose.
Searching for alternative galactose PTS in L. lactis using transcriptomics. Our data strongly indicate that strain NZ9000⌬galP transports galactose via an unknown PTS transporter(s) displaying low affinity for the sugar. Previously, a transcriptome analysis approach proved useful to identify PTS Cel as an additional glucose transporter in L. lactis (51) . Assuming that the galactose PTS would be expressed at a higher level in the galP mutant when it was grown on galactose, using full-genome L. lactis DNA microarrays, we compared the mRNA levels of galactose-grown NZ9000⌬galP cells with those of glucosegrown NZ9000⌬galP or galactose-grown NZ9000. Genes encoding PTS proteins and their respective expression levels under the conditions studied are shown in Table 4 . On galactosegrown cells, loss of GalP did not significantly alter the expression of genes encoding PTS components, the exception being llmg_pseudo_54. L. lactis MG1363 llmg_pseudo_54, yidB in strain IL1403, is annotated as a putative cellobiose-specific PTS IIC component (10) . Curiously, when galactose-and glucose-grown NZ9000⌬galP cells are compared, llmg_pseudo_54 showed the second-highest fold overexpression, after ptcA. However, the frameshift mutation in llmg_pseudo_54 (nucleotide 422 is missing) was confirmed by (re)sequencing llmg_ pseudo_54 from strains MG1363, NZ9000, and NZ9000⌬galP (grown on glucose or galactose), and thus, this gene fragment does not seem to produce a functional protein in either strain. Identification of the galactose PTS is hindered by the number of PTS-encoding genes (55% of the total) upregulated in galactosegrown NZ9000⌬galP compared to the number in glucose-grown cells.
Engineering strategies to improve the capacity for galactose utilization. From our results on the characterization of the galactose dissimilation routes, engineering the Leloir pathway appeared to be the most promising strategy to increase galactose consumption in L. lactis NZ9000 since (i) the strain possessing the GalP/Leloir pathway showed the highest rate of galactose utilization and (ii) the PTS Lac and the galactose PTS in L. lactis NZ9000⌬galP display an apparent low affinity for galactose. Furthermore, improving the capacity to use galactose is likely to require increased ␣-PGM activity, as this enzyme was shown to be a metabolic bottleneck in galactose metabolism (45) . Because the native ␣-PGM, an enzyme essential for growth, may be tied to unknown physiological control elements in L. lactis, we chose to bypass it by engineering the expression of S. thermophilus pgmA, together with the lactococcal gal operon genes galPMKT.
The genes galPMKT were cloned in pNZ8048, downstream of the nisin-inducible promoter, and the resulting vector, pGalPMKT, was introduced into L. lactis NZ9000. The S. thermophilus pgmA was cloned downstream of galT in pGalPMKT. Nisin-inducible expression of the Leloir genes (galPMKT) alone or together with pgmA in NZ9000 was examined by SDS-PAGE. Bands due to GalP (50.5 kDa) and GalK (43.7 kDa), but not GalM (37.6 kDa) or GalT (56.3 kDa), were detected in NZ9000(pGalPMKT). Besides GalP and GalK, an additional band due to ␣-PGM was readily detected in the crude extracts of NZ9000(pGalPMKTpgmA) (data not shown).
In addition, a 3-fold increased ␣-PGM activity was present in the crude extracts of induced NZ9000(pGalPMKTpgmA) compared to that observed in NZ9000(pNZ8048) ( Table 5) , demonstrating the functional overexpression of pgmA.
To examine the effect of overproducing the genes in the gal operon alone or in combination with ␣-PGM, in vivo NMR coupled to 13 C labeling was used to follow the metabolism of galactose in suspensions of nongrowing cells (Fig. 6 ). All strains were grown in CDM containing galactose and were induced with nisin (0.01% [vol/vol] supernatant of NZ9700) at an OD 600 of 0.5.
Nisin-induced expression of galPMKT did not improve galactose consumption in strain NZ9000 (compare Fig. 6A with  6C) . Instead, it caused increases of about 5 and 15 mM in the maximal concentrations of the Leloir pathway intermediates ␣-Gal1P and ␣-G1P, respectively. These data are in line with the fact that wild-type ␣-PGM activity is insufficient to support a high flux via the Leloir pathway (45) . Indeed, coexpression of pgmA together with the gal operon genes reduced the ␣-Gal1P and ␣-G1P pools by approximately 3-fold and led to a 38% increase in the galactose consumption rate (Fig. 6B) . Previously, a 6-fold increase in the native ␣-PGM activity resulted in a 25% greater galactose consumption rate (45) . As expected, nisin-induced expression of the streptococcal pgmA per se also had a positive effect on the galactose consumption rate (an increase of about 19% when the ␣-PGM activity was 3.8 times higher; Table 5 ). Altogether these results prompted a pull-andpush strategy that consisted of cloning the first gene needed for galactose utilization, the galactose permease, and pgmA, the gateway to glycolysis, with the obvious advantage being that only two genes needed to be cloned. Under the conditions studied, the resulting strain, NZ9000(pGalPpgmA), presented the highest galactose consumption rate, which was increased 50% compared to that for control strain NZ9000(pNZ8048). Furthermore, ␣-Gal1P and ␣-G1P levels were even lower than those in strain NZ9000(pGalPMKTpgmA) (compare Fig. 6B  with 6D ). Curiously, increasing the galactose consumption rate led to an FBP profile more similar to that observed during the a Galactose was present at 1% (wt/vol). Induction was performed by adding a supernatant (0.01%, vol/vol) of a full-grown culture of the nisin producer L. lactis NZ9700 when an OD 600 of 0.25 was reached.
b Relative to that in the empty vector pNZ8048 control strain. The results are averages of two independent cultivations, and the error is below 10%.
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metabolism of glucose (45) . Our data show that to improve galactose utilization in L. lactis subsp. cremoris, at least ␣-PGM and galactose uptake activities must be above the wild-type levels.
DISCUSSION
In the 1970s and early 1980s, the efforts of several laboratories to elucidate galactose metabolism in L. lactis led to the publication of conflicting results regarding the uptake step and the relative contributions/efficiencies of the Leloir and Tag6P pathways. In this work, we used directed genetically engineered strains to examine galactose utilization via the chromosomal Leloir pathway or the plasmid-encoded Tag6P pathway in L. lactis subsp. cremoris NZ9000. This strain lacks a lactose plasmid (Tag6P pathway) but possesses the gal operon (galPMKTE), which encodes a galactose permease (galP) and the enzymes of the Leloir pathway. Assessment of Tag6P pathway activity in strain NZ9000 requires inactivation of the Leloir route. To this end, galP-and galPMK-deletion strains were constructed, but growth on galactose was abolished only when a gal operon fragment covering galP, galM, and galK was removed. Thus, GalM and/or GalK is crucial for growth of strain NZ9000 on galactose, whereas GalP is not. GalM is not present in all bacteria known to metabolize galactose via the Leloir pathway (1), most likely because the anomerization reaction catalyzed by the mutarotase (␤-Gal 7 ␣-Gal) can occur spontaneously in solution. On the other hand, loss of GalK abolished galactose fermentation in L. lactis MG1363 (25) and severely impaired growth of the phylogenetically related organisms Streptococcus mutans and Streptococcus salivarius (1, 14) , denoting the key role of the kinase in organisms relying on the Leloir pathway for galactose utilization. In fact, a low level of expression of galK and, thus, insufficient galactokinase activity could explain the inability of a previously described lactococcal galP-disruption mutant (MG1363 galP::ery) to grow on galactose (25) . Interestingly, this galP-disruption mutant displayed galactose uptake activity (25) , which corroborates the occurrence of an additional transporter(s) with specificity for galactose in L. lactis MG1363 and derivatives.
Detection of galactose phosphorylated at position C-6 (Gal6P) both in the galP mutant and in NZ9000 by in vivo NMR strongly indicated galactose PTS activity, since the formation of Gal6P is usually associated with translocation of galactose or lactose via PTS transporters in bacteria. To the best of our knowledge, production of Gal6P through galactokinase phosphorylation on C-6 or a phosphogalactomutase activity (interconversion of ␣-Gal1P and Gal6P) has never been reported. In agreement, we failed to detect either activity in cell extracts of strain NZ9000⌬galP by 31 P NMR analysis. Galactose PTS activity was, however, readily measured in permeabilized cells of galactose-grown NZ9000⌬galP. Thus, strain NZ9000 possesses a PTS for galactose uptake, in addition to the secondary carrier GalP (Fig. 1) . The presence of a galactose PTS in strains ML3 and C2, which, like strain NZ9000, derive from the dairy strain L. lactis NCDO712, has been suggested (50, 59) . In an attempt to identify the additional galactose PTS, we used a transcriptomics approach and compared mRNA levels of galactosegrown and glucose-grown NZ9000⌬galP. In L. lactis MG1363, FIG. 6 . Galactose consumption and time courses for ␣-Gal1P, ␣-G1P, and FBP pools in resting cells of L. lactis strains engineered to improve galactose utilization. [1- 13 C]galactose (20 mM) was supplied at time 0 min to nongrowing suspensions of strains NZ9000(pGalPMKT) (A), NZ9000(pGalPMKTpgmA) (B), control strain NZ9000(pNZ8048) (C), and NZ9000(pGalPpgmA) (D); and its metabolism was monitored by in vivo 13 C NMR under anaerobic conditions at pH 6.5 and 30°C. Maximal galactose consumption rates (mol min Ϫ1 mg protein GalP, the galactose consumption rate slowed markedly at concentrations of galactose in the medium of about 6 to 7 mM. The strain equipped with GalP (NZ9000) showed the highest rate of galactose consumption, while the lowest was observed in the strain mainly importing galactose via PTS Lac [NZ9000⌬galPMK(pMG820)] (Fig. 4) . The data pinpoint GalP as the transporter displaying the highest capacity to take up galactose. In summary, the GalP/Leloir pathway consumes galactose faster and is fully active with galactose at concentrations down to about 1.5 mM. Given these properties, the GalP/ Leloir route appeared to be the best target for manipulations aiming at enhanced galactose consumption in L. lactis. Overexpression of the gal genes (galPMKT) in strain NZ9000 did not lead to an enhanced galactose consumption rate. A considerable increase in the maximal concentrations of the phosphorylated Leloir intermediates ␣-Gal1P and ␣-G1P pointed to an obstruction at the level of ␣-PGM. This result was not completely unexpected, as we have recently shown that the step catalyzed by ␣-PGM is a major bottleneck in the utilization of galactose (45) . In line with this observation, the ␣-PGM step was also critical for the improvement of the galactose uptake capacity in Saccharomyces cerevisiae (12) . In the present study, overproduction of a heterologous ␣-PGM (from S. thermophilus) alone or in combination with gal gene products, namely, GalP or GalPMKT, resulted in higher galactose consumption rates. The best performance, corresponding to a 50% increase relative to wild-type levels, was obtained with the NZ9000 strain that overexpressed the genes encoding GalP and ␣-PGM. However, the galactose consumption rate in this engineered strain is 2-fold lower than the rate of glucose utilization in strain NZ9000 (13) . Although a full explanation cannot be put forward at this stage, it would not be surprising if regulatory events such as CcpA-mediated regulation of catabolic genes are involved. CcpA-mediated activation of the las operon (pfk, pyk, and ldh) is not in effect during growth on galactose (40, 66) , which could in part explain the decreased glycolytic flux. In view of these findings, we postulate that further improvement of galactose utilization may require engineering of regulatory genes, such as ccpA or even specific sugar regulators. Future approaches, combining increased expression of catabolic genes, namely, galactose permease and ␣-PGM, with engineering of the catabolite control network could create L. lactis strains preferring galactose over glucose and lactose, a desirable trait considering that the concentration of lactose in milk fermentations is normally higher than that of galactose (3). Thus, galactose scavengers would be ideal starters in the manufacture of galactose-free dairy products.
